Deep Analysis Earnings Calendar About

Home
/KPTI Karyopharm Therapeutics Inc.
/Deep Analysis

Karyopharm Therapeutics Inc.KPTIEarnings & Financial Report

Nasdaq · Health Care · Pharmaceutical Preparations

Financial
Deep Analysis
Ownership
Annual Changes

ZVRA

ZEVRA THERAPEUTICS, INC.

Revenue

$34.1M

Net Profit

N/A

INCR

Intercure Ltd.

Revenue

$35.1M

Net Profit

N/A

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

Revenue

$32.6M

Net Profit

$11.4M

CCG

Cheche Group Inc.

Revenue

$32.8M

Net Profit

$153.6K

$LIFECORE BIOMEDICAL, INC. \DE\$

LFCR

LIFECORE BIOMEDICAL, INC. \DE\

Revenue

$31.1M

Net Profit

$-10.0M

GYRE

GYRE THERAPEUTICS, INC.

Revenue

$37.2M

Net Profit

$-1.4M

CHCI

Comstock Holding Companies, Inc.

Revenue

$23.9M

Net Profit

$13.5M

URGN

UroGen Pharma Ltd.

Revenue

$37.8M

Net Profit

N/A

ZVRA

ZEVRA THERAPEUTICS, INC.

Revenue

$34.1M

Net Profit

N/A

INCR

Intercure Ltd.

Revenue

$35.1M

Net Profit

N/A

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

Revenue

$32.6M

Net Profit

$11.4M

CCG

Cheche Group Inc.

Revenue

$32.8M

Net Profit

$153.6K

$LIFECORE BIOMEDICAL, INC. \DE\$

LFCR

LIFECORE BIOMEDICAL, INC. \DE\

Revenue

$31.1M

Net Profit

$-10.0M

GYRE

GYRE THERAPEUTICS, INC.

Revenue

$37.2M

Net Profit

$-1.4M

CHCI

Comstock Holding Companies, Inc.

Revenue

$23.9M

Net Profit

$13.5M

URGN

UroGen Pharma Ltd.

Revenue

$37.8M

Net Profit

N/A

The financial landscape of a US public company. Updated every quarter.

Explore

Home
Deep Analysis
Earnings Calendar

About

About
Terms
Contact Us

For informational purposes only. Not financial advice.

© 2026 10q10k.net · All rights reserved.